Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders | MicrobiomeTrials← Back to trialsNCT02567175
Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
NO_LONGER_AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Gastric Content Aspiration RiskGastrointestinal EndoscopyAnesthesia Complications
This prospective observational study aims to validate the BBCMADE nomogram (Body Mass Index, Brain infarction, Cirrhosis…
Bursa, Turkey (Türkiye)Completed Feb 20, 2026
GERD (Gastroesophageal Reflux Disease)
The purpose of this pilot clinical study is to evaluate the feasibility and safety of an innovative endoscopic treatment…
Multiple LocationsEst. completion Sep 2026
ENROLLING_BY_INVITATION
The goal of this observational study is to identify the impact of incretin-based obesity medications (e.g., GLP-1 and GL…
Indianapolis, United StatesCompleted Dec 31, 2029